The clinical significance of CXCL5 in non-small cell lung cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• DholariaBHammondWShredersALouYEmerging therapeutic agents for lung cancerJ Hematol Oncol20169113827938382
   PubMed Web of Science ®Google Scholar
• WeiSWangKLong noncoding RNAs: pivotal regulators in acute myeloid leukemiaExp Hematol Oncol201653027999732
   PubMedGoogle Scholar
• LiuQYuSLiAXuHHanXWuKTargeting interlukin-6 to relieve immunosuppression in tumor microenvironmentTumour Biol2017396 1010428317712445
   Google Scholar
• LiuQLiATianYThe CXCL8-CXCR1/2 pathways in cancerCytokine Growth Factor Rev201631617127578214
   PubMed Web of Science ®Google Scholar
• KowalczukOBurzykowskiTNiklinskaWEKozlowskiMChyczewskiLNiklinskiJCXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genesTumour Biol20143554619462824500664
   PubMedGoogle Scholar
• GaoYGuanZChenJCXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9Int J Oncol201547269070026058729
   PubMed Web of Science ®Google Scholar
• ZhaoJOuBHanDTumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathwaysMol Cancer20171617028356111
   PubMedGoogle Scholar
• HsuYLHouMFKuoPLHuangYFTsaiEMBreast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathwayOncogene201332374436444723045282
   PubMed Web of Science ®Google Scholar
• NajjarYGRaymanPJiaXMyeloid-derived suppressor cell subset accumulation in renal cell carcinoma parenchyma is associated with intratumoral expression of IL1β, IL8, CXCL5, and Mip-1αClin Cancer Res20172392346235527799249
   PubMedGoogle Scholar
• ZhouSLDaiZZhouZJOverexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinomaHepatology20125662242225422711685
   PubMed Web of Science ®Google Scholar
• YeudallWAVaughanCAMiyazakiHGain-of-function mutant p53 upregulates CXC chemokines and enhances cell migrationCarcinogenesis201233244245122114072
   PubMedGoogle Scholar
• WangICMelitonLTretiakovaMCostaRHKalinichenkoVVKalinTVTransgenic expression of the forkhead box M1 transcription factor induces formation of lung tumorsOncogene200827304137414918345025
   PubMedGoogle Scholar
• ZhuXQiaoYLiuWCXCL5 is a potential diagnostic and prognostic marker for bladder cancer patientsTumor Biol201637445694577
   PubMedGoogle Scholar
• OkabeHBeppuTUedaMIdentification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblastsInt J Cancer2012131102234224122337081
   PubMedGoogle Scholar
• XuHWuKJTianYCD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancerInt J Oncol20164941343135027499099
   PubMed Web of Science ®Google Scholar
• XuHYuSYuanXXiongJKuangDPestellRGWuKDACH1 suppresses breast cancer as a negative regulator of CD44Sci Rep201771436128659634
   PubMedGoogle Scholar
• XuHWuKJTianYExpression profile of SIX family members correlates with clinic-pathological feature and prognosis of breast cancer: a systematic review and meta-analysisMedicine (Baltimore)20169527e408527399099
   PubMed Web of Science ®Google Scholar
• BildAHYaoGChangJTOncogenic pathway signatures in human cancers as a guide to targeted therapiesNature2006439707435335716273092
   PubMed Web of Science ®Google Scholar
• TakeuchiTTomidaSYatabeYExpression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviorsJ Clin Oncol200624111679168816549822
   PubMed Web of Science ®Google Scholar
• ZhuCQDingKStrumpfDPrognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancerJ Clin Oncol201028294417442420823422
   PubMed Web of Science ®Google Scholar
• XieYXiaoGCoombesKRRobust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patientsClin Cancer Res201117175705571421742808
   PubMed Web of Science ®Google Scholar
• RousseauxSDebernardiAJacquiauBEctopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancersSci Transl Med20135186186ra66
   PubMed Web of Science ®Google Scholar
• OkayamaHKohnoTIshiiYIdentification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomasCancer Res201272110011122080568
   PubMed Web of Science ®Google Scholar
• BotlingJEdlundKLohrMBiomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationClin Cancer Res201319119420423032747
   PubMed Web of Science ®Google Scholar
• TangHXiaoGBehrensCA 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patientsClin Cancer Res20131961577158623357979
   PubMed Web of Science ®Google Scholar
• DerSDSykesJPintilieMValidation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patientsJ Thorac Oncol201491596424305008
   PubMed Web of Science ®Google Scholar
• LeeESSonDSKimSHPrediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expressionClin Cancer Res200814227397740419010856
   PubMed Web of Science ®Google Scholar
• KunerRMuleyTMeisterMGlobal gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypesLung Cancer2009631323818486272
   PubMed Web of Science ®Google Scholar
• BatyFFacompréMKaiserSGene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancerAm J Respir Crit Care Med2010181218118819833826
   PubMed Web of Science ®Google Scholar
• HouJAertsJden HamerBGene expression-based classification of non-small cell lung carcinomas and survival predictionPLoS One201054e1031220421987
   PubMed Web of Science ®Google Scholar
• TarcaALLauriaMUngerMStrengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature ChallengeBioinformatics201329222892289923966112
   PubMed Web of Science ®Google Scholar
• LandiMTDrachevaTRotunnoMGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalPLoS One200832e165118297132
   PubMed Web of Science ®Google Scholar
• TomidaSTakeuchiTShimadaYRelapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosisJ Clin Oncol200927172793279919414676
   PubMed Web of Science ®Google Scholar
• LuTPTsaiMHLeeJMIdentification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking womenCancer Epidemiol Biomarkers Prev201019102590259720802022
   PubMed Web of Science ®Google Scholar
• SelamatSAChungBSGirardLGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expressionGenome Res20122271197121122613842
   PubMed Web of Science ®Google Scholar
• RaponiMZhangYYuJGene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lungCancer Res200666157466747216885343
   PubMed Web of Science ®Google Scholar
• Director’s Challenge Consortium for the Molecular Classification of Lung AdenocarcinomaSheddenKTaylorJMGene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNat Med200814882282718641660
   PubMed Web of Science ®Google Scholar
• BeerDGKardiaSLHuangCCGene-expression profiles predict survival of patients with lung adenocarcinomaNat Med20028881682412118244
   PubMed Web of Science ®Google Scholar
• LiuQLiATianYThe expression profile and clinic significance of the SIX family in non-small cell lung cancerJ Hematol Oncol20169111927821176
   PubMedGoogle Scholar
• TianYLiuQHeXEmerging roles of Nrf2 signal in non-small cell lung cancerJ Hematol Oncol2016911426922479
   PubMedGoogle Scholar
• SunWYuanXTianYNon-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerJ Hematol Oncol201589526227959
   PubMed Web of Science ®Google Scholar
• GuoKZhangZPHanLDetection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancerOnco Targets Ther201583289329626609241
   PubMed Web of Science ®Google Scholar
• XiaQSXuJChenHYAssociation between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature reviewOnco Targets Ther201693917392327418836
   PubMed Web of Science ®Google Scholar
• ShenLWuXTanJCombined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancerOnco Targets Ther2017103545355628790847
   PubMedGoogle Scholar
• ArenbergDAKeaneMPDiGiovineBEpithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancerJ Clin Invest199810234654729691082
   PubMed Web of Science ®Google Scholar
• PõldMZhuLXSharmaSCyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancerCancer Res20046451853186014996749
   PubMedGoogle Scholar
• SaintignyPMassarelliELinSCXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinomaCancer Res201373257158223204236
   PubMed Web of Science ®Google Scholar
• ShielsMSPfeifferRMHildesheimACirculating inflammation markers and prospective risk for lung cancerJ Natl Cancer Inst2013105241871188024249745
   PubMedGoogle Scholar
• SpaksARole of CXC group chemokines in lung cancer development and progressionJ Thorac Dis20179Suppl 3S164S17128446981
   PubMedGoogle Scholar
• HanNYuanXWuHDACH1 inhibits lung adenocarcinoma invasion and tumor growth by expressing CXCL5 signalingOncotarget2015685877588825788272
   PubMedGoogle Scholar
• ZhouSLZhouZJHuZQCXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signalingCancer Lett2015358212413525462858
   PubMed Web of Science ®Google Scholar
• LimJBChungHWSerum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancerCytokine2015731162225689618
   PubMedGoogle Scholar
• ZhangHXiaWLuXA novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patientsPLoS One201382e5783023469080
   PubMedGoogle Scholar
• YanagawaJWalserTCZhuLXSnail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinomaClin Cancer Res200915226820682919887480
   PubMed Web of Science ®Google Scholar
• KuoPLChenYHChenTCShenKHHsuYLCXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathwayJ Cell Physiol201122651224123120945384
   PubMedGoogle Scholar
• LiAKingJMoroAOverexpression of CXCL5 is associated with poor survival in patients with pancreatic cancerAm J Pathol201117831340134921356384
   PubMed Web of Science ®Google Scholar
• KawamuraMToiyamaYTanakaKCXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancerEur J Cancer201248142244225122197219
   PubMed Web of Science ®Google Scholar
• XiaJXuXHuangPHeMWangXThe potential of CXCL5 as a target for liver cancer-what do we know so far?Expert Opin Ther Targets201519214114625495348
   PubMed Web of Science ®Google Scholar
• HeiskanenMcaArray_meyer-00191: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Available from: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83227Accessed November 15, 2017
   Google Scholar